Quantum Biopharma (QNTM) Long-Term Investments (2018 - 2025)

Quantum Biopharma has reported Long-Term Investments for 8 years, with the latest figure at $2224.0 in Q1 2025.

• Quarterly Long-Term Investments changed N/A year-over-year to $2224.0 in Q1 2025, while the trailing twelve-month figure through Mar 2025 was $2224.0 (changed N/A YoY) and the FY2024 annual result came in at $2224.0, down 63.23% from the prior year.
• Long-Term Investments held at $2224.0 in Q1 2025 per QNTM's latest filing, from $2224.0 in the prior quarter.
• Over five years, Long-Term Investments peaked at $827612.0 in Q4 2022 and troughed at $2224.0 in Q4 2024.
• A 5-year average of $215729.4 and a median of $5926.0 in 2024 frame the typical range for Long-Term Investments.
• The sharpest annual moves came in 2022 and 2023: Long-Term Investments rose 25.35% in 2022, then plunged 99.27% in 2023.
• Over 5 years, Long-Term Investments stood at $660226.0 in 2021, then rose by 25.35% to $827612.0 in 2022, then slumped by 99.27% to $6049.0 in 2023, then plunged by 63.23% to $2224.0 in 2024, then changed by 0.0% to $2224.0 in 2025.
• According to Business Quant data, Long-Term Investments over the past three periods registered $2224.0, $2224.0, and $5926.0 for Q1 2025, Q4 2024, and Q3 2024 respectively.